- Details
- Written by ADA
- Category: Health News
Orlando, Florida - People with diabetes who have experienced recent acute coronary syndrome (ACS) and take a combination of alirocumab and statins may reduce their risk of future cardiac events by more than double that of people on the same medication regimen who have similar cardiac histories, but have prediabetes or normal blood glucose levels, according to the study, “Alirocumab and Cardiovascular Outcomes in Patients with Acute Coronary Syndrome (ACS) and Diabetes - Prespecified Analyses of ODYSSEY OUTCOMES,” presented at the American Diabetes Association’s® (ADA’s) 78th Scientific Sessions® at the Orange County Convention Center.
- Details
- Written by State Department
- Category: Health News
Washington, DC - The U.S. Asia-Pacific Economic Cooperation (APEC) Science Prize for Innovation, Research, and Education (ASPIRE) Competition named Dr. Kara Spiller of Drexel University as the 2018 U.S. nominee to represent the United States for the APEC-wide ASPIRE Prize.
- Details
- Written by State Department
- Category: Health News
Washington, DC - The following statement was released by the Governments of the United States of America and Australia regarding cooperation on health security as discussed at the 2018 Australia-U.S. Ministerial Consultations (AUSMIN).
- Details
- Written by IVN
- Category: Health News
Washington, DC - CDC advises consumers and retailers not to eat, serve, or sell Hy-Vee Spring Pasta Salad, which has been linked to a multistate outbreak of Salmonella infections.
- Details
- Written by Rachel Dowd
- Category: Health News
Los Angeles, California - The longest-running prospective study on sexual minority parent families found that 25-year-olds raised by lesbian parents do as well on multiple measures of psychological health as adults from a population-based sample. The researchers compared relationships, educational/job performance, and behavioral, emotional and mental health problems in the two samples.
- Details
- Written by Sandy Walsh
- Category: Health News
Washington, DC - The U.S. Food and Drug Administration today approved Tibsovo (ivosidenib) tablets for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) who have a specific genetic mutation. This is the first drug in its class (IDH1 inhibitors) and is approved for use with an FDA-approved companion diagnostic used to detect specific mutations in the IDH1 gene in patients with AML.
Page 11 of 361
